This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Wickramasinghe,_S.R.
There is no page with the exact title "Wickramasinghe,_S.R.". The search results for "Wickramasinghe,_S.R." are displayed below. You can create a page titled Wickramasinghe,_S.R. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Wickramasinghe W (47 bytes)
1: List of pages with the keyword Wickramasinghe W - Category:Wickramasinghe NP (48 bytes)
1: List of pages with the keyword Wickramasinghe NP - Category:Wickramasinghe, N P (50 bytes)
1: List of pages with the keyword Wickramasinghe, N P - Category:Wickramasinghe, W A (50 bytes)
1: List of pages with the keyword Wickramasinghe, W A - Category:Wickramasinghe, W (48 bytes)
1: List of pages with the keyword Wickramasinghe, W - Category:Wickramasinghe, S R (50 bytes)
1: List of pages with the keyword Wickramasinghe, S R - Category:Wickramasinghe WA (48 bytes)
1: List of pages with the keyword Wickramasinghe WA - Category:Wickramasinghe SR (48 bytes)
1: List of pages with the keyword Wickramasinghe SR
Page text matches
- Category:Wickramasinghe W (47 bytes)
1: List of pages with the keyword Wickramasinghe W - 2c07 (4,787 bytes)
2: ==Oxoacyl-ACP reductase of Plasmodium falciparum==
3: ...aption='[[2c07]], [[Resolution|resolution]] 1.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2C07 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.5Å</td></tr> - 1b6j (11,642 bytes)
2: ...COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1==
3: ...aption='[[1b6j]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1B6J FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 1b6k (11,713 bytes)
2: ...COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5==
3: ...aption='[[1b6k]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1B6K FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 1b6l (11,690 bytes)
2: ...COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4==
3: ...aption='[[1b6l]], [[Resolution|resolution]] 1.75Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1B6L FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.75Å</td></tr> - 1b6m (11,683 bytes)
2: ...COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6==
3: ...aption='[[1b6m]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1B6M FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 1b6p (11,700 bytes)
2: ...COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7==
3: ...aption='[[1b6p]], [[Resolution|resolution]] 2.00Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1B6P FirstGlance]. <br>
6: ...action, [[Resolution|Resolution]] 2Å</td></tr> - 1mtr (9,356 bytes)
2: ... WITH A CYCLIC PHE-ILE-VAL PEPTIDOMIMETIC INHIBITOR==
3: ...aption='[[1mtr]], [[Resolution|resolution]] 1.75Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1MTR FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.75Å</td></tr> - 1z1h (11,757 bytes)
2: ...complexed with macrocyclic peptidomimetic inhibitor 3==
3: ...aption='[[1z1h]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1Z1H FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 1z1r (11,759 bytes)
2: ...complexed with Macrocyclic peptidomimetic inhibitor 2==
3: ...aption='[[1z1r]], [[Resolution|resolution]] 1.85Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=1Z1R FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 1.85Å</td></tr> - 3v19 (4,076 bytes)
2: ...amp mechanism-based application of protein engineering to global health==
3: ...aption='[[3v19]], [[Resolution|resolution]] 2.00Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3V19 FirstGlance]. <br>
6: ...action, [[Resolution|Resolution]] 2Å</td></tr> - 3v1g (4,135 bytes)
2: ...amp mechanism-based application of protein engineering to global health==
3: ...aption='[[3v1g]], [[Resolution|resolution]] 2.20Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=3V1G FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.2Å</td></tr> - 4nib (5,724 bytes)
2: ==Crystal structure of human insulin mutant B20 D-ala, B23 D-ala==
3: ...aption='[[4nib]], [[Resolution|resolution]] 1.40Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=4NIB FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.4Å</td></tr> - 4oga (10,133 bytes)
2: ...n complex with Site 1 of the human insulin receptor==
3: ...aption='[[4oga]], [[Resolution|resolution]] 3.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=4OGA FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 3.5Å</td></tr> - 2mli (5,518 bytes)
2: ==NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin==
3: <StructureSection load='2mli' size='340' side='right'caption='[[2mli]]' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2MLI FirstGlance]. <br>
6: ...-2-AMINO-3-PHENYLACRYLIC+ACID'>23F</scene></td></tr> - 4p65 (6,277 bytes)
2: ==Crystal structure of an cyclohexylalanine substituted insulin anal...
3: ...aption='[[4p65]], [[Resolution|resolution]] 1.50Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=4P65 FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 1.5Å</td></tr> - Category:Wickramasinghe NP (48 bytes)
1: List of pages with the keyword Wickramasinghe NP - 2mpi (3,479 bytes)
2: ==Solution structure of B24G insulin==
3: <StructureSection load='2mpi' size='340' side='right'caption='[[2mpi]]' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=2MPI FirstGlance]. <br>
6: ...at" id="methodDat">Solution NMR, 18 models</td></tr> - 4tth (4,091 bytes)
2: ... structure of a CDK6/Vcyclin complex with inhibitor bound==
3: ...aption='[[4tth]], [[Resolution|resolution]] 2.90Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=4TTH FirstGlance]. <br>
6: ...tion, [[Resolution|Resolution]] 2.9Å</td></tr> - 8gc1 (3,779 bytes)
2: ...ancestor (UCA) of the PC39-1 anti-HIV broadly neutralizing antibody lineage==
3: ...aption='[[8gc1]], [[Resolution|resolution]] 3.19Å' scene=''>
4: == Structural highlights ==
5: ...teopedia.org/fgij/fg.htm?mol=8GC1 FirstGlance]. <br>
6: ...ion, [[Resolution|Resolution]] 3.19Å</td></tr>
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
